Yun Xu, Yuchen Wu, Yuedi Dai, Xiaopin Ji, Zhe Cui, Xiaodong Zhu, Ye Xu. "Fruquintinib combined with FOLFIRI/mFOLFOX6 as second-line treatment in patients with RAS-mutant metastatic colorectal cancer (mCRC): A multicenter, open-label, phase II study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.151